Navigation Links
Vivo Ventures Announces Promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner
Date:5/25/2011

PALO ALTO, Calif., May 25, 2011 /PRNewswire/ -- Vivo Ventures, LLC (“Vivo”) announced today the promotions of Dr. Chen Yu and Dr. James Zhao to Managing Partner in recognition of their contributions to the firm.

Dr. Yu first joined Vivo in 2004 and has been a Partner since 2007.   He currently serves as a Director of Sagent Pharmaceuticals, Nora Therapeutics and Synaptic International, and has been actively involved in many of the firm’s earlier private and public investments, including China KangHui Holdings, Achillion, Transcept, Tranzyme and Cubist.  In addition, he has had an operational role in a part-time capacity as Chief Business Officer of China KangHui Holdings overseeing their corporate development and investor relations efforts.  Prior to his time at Vivo, Dr. Yu was an early employee at aQuantive, which listed on Nasdaq in 2000 and ultimately was acquired for $6.5B by Microsoft.  Dr. Yu also currently serves on the Board of Governors for the Stanford Medical School Alumni Association.  Dr. Yu received his B.A. from Harvard University; his M.D. and MBA degrees are both from Stanford.

Dr. Zhao first began working with the firm in late 2005.  With his promotion to Managing Partner, he will now be heading Vivo’s China team.  He has made significant contributions to the firm’s success in China, including opening its Shanghai and Chengdu offices.  He was also instrumental in assisting in the formation of Vivo’s RMB denominated fund in partnership with the Chengdu Hi Tech Yinke Fund.  Dr. Zhao is actively involved in all of Vivo’s investments in China and will serve as the lead Vivo representative for Shanghai Hile, Sundise, and IMH.  Prior to joining Vivo, Dr. Zhao was a consultant with the Monitor Group focusing on life sciences.  Prior to that, he worked as a sales supervisor for Bristol Myers Squibb in Chengdu.  Dr. Zhao received his medical degree from West China University of Medical Sciences in Chengdu, his M.S. in Molecular Biology from Vrije University in Brussels, and his M.B.A. from Washington University, St. Louis.

"We are pleased to recognize the contributions of our new Managing Partners as we continue to strengthen and grow our team in the U.S. and in China,” said Frank Kung, Vivo Ventures co-founder and Senior Managing Partner.

About Vivo Ventures

Vivo Ventures is a life-sciences focused venture capital firm formed in 1996 with over $750M under management. With over 90 years of scientific and operational expertise in biotechnology, Vivo makes investment decisions for the Funds and helps its portfolio companies develop corporate strategy, arrange licensing agreements and strategic alliances, recruit key management personnel, and acquire new products and technology to accelerate growth. Its current portfolio includes more than 60 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. For more information, please visit www.vivoventures.com.


'/>"/>
SOURCE Vivo Ventures, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. XDATA Retains Adapt IP Ventures to Market Patents and Technology for Automated 3D Ultrasound Imaging System
2. Aethlon Medical to Present the Aethlon ADAPT™ System at C21 BioVentures™ Life Sciences Partnering Conference
3. JumpStart Ventures Invests in Cleveland-based SPR Therapeutics
4. MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
5. JumpStart Ventures and Cleveland Clinic Invest in SironRX Therapeutics
6. Leader Ventures Supports Innovative Drug Discovery Company Carmot
7. PharmaVentures Appoints Paul Phull as Senior Director
8. SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
9. JumpStart Ventures Invests In and Provides Entrepreneurial Assistance to Drug Development Company
10. Sangon & Bio Basic Inc. Closes $10 Million Round of Investment by Qiming Ventures
11. BIO Ventures for Global Health Opens San Francisco Office; Hires New Senior Staff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017   The ... organization within medical affairs in the pharmaceutical industry ... the chair of a newly formed scientific advisory ... members to form the first ever medical affairs ... For more information about the ACMA, please visit  ...
(Date:3/24/2017)... FinancialBuzz.com News Commentary   ... Medical cannabis products around the world are projected to gain popularity. A ... market will reach a value of USD 55.8 billion by 2025. ... growing industry. By the end of 2016, 28 states have now laws ... conservative states like Arkansas and North ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, ... Master in Frederick, MD. Judy says, “I am passionate about sharing Reiki as ... a very difficult and challenging time.” , A Certified Medical Reiki™ Master trained ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A ... minister and college Bible teacher residing in North Carolina with his wife, Anna Marie. ... blessed them with six grandchildren. David is also the author of “Shadow and Substance.” ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World Health Organization declared the ... four million Zika-related cases in the Americas within the next year. Lyme disease is ... per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme and other insect borne ...
(Date:3/23/2017)... ... March 23, 2017 , ... Demonstrating their commitment to ... public health departments have been awarded national accreditation through the Public Health ... the expanding network of communities across the nation whose health departments meet rigorous ...
(Date:3/23/2017)... ... March 23, 2017 , ... The IoT (Internet of Things) is revolutionizing ... a huge impact on businesses and individual consumers alike. Laboratories can maximize their ... a value anywhere from $4 trillion to $11 trillion dollars by the year 2025. ...
Breaking Medicine News(10 mins):